Skip to main content
. Author manuscript; available in PMC: 2011 May 15.
Published in final edited form as: Clin Cancer Res. 2010 May 11;16(10):2803–2810. doi: 10.1158/1078-0432.CCR-10-0026

Figure 4.

Figure 4

MRFDG (µmol/min/100 g) and BF (mL/min/g) for each subtype. Light shaded symbols represent non-responders, dark shaded symbols represent patients who achieved pathologic complete response (pCR). ● represents pCR in TN tumors, ■ represents pCR in HER2 tumors, ▲ represents pCR in luminal tumors.